Ncardia at ACT 2026
Nov 15–18, 2026 San Antonio, TX ~1.4k attendees Website
Ncardia takes part in 3 sessions at ACT 2026 in San Antonio. Its program centres on stem cell-derived human and monkey cells as new approach methods for early safety testing, such as heart muscle cells from nonhuman primates for cardiac safety. It also covers a multi-tissue human platform for profiling antibody-drug conjugate toxicity.
| Organization | ACT 2026 Attendance |
|---|---|
◆Platinum Supporter | |
Supplies human iPSC-derived cell models and runs iPSC-based assay services for drug discovery, cardiac safety and disease modeling. | Poster Mon Nov 16 5:00pm–6:30pm Poster Mon Nov 16 5:00pm–6:30pm Talk Wed Nov 18 12:00pm–12:55pm |
Instantly find 20 buyers from Ncardia
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American College of Toxicology (ACT). Organization details are derived from ACT’s published program, exhibitor floor plan and supporter list, and each organization’s own website. Submit a correction